Last week Vermont became the first state to provide a glimpse of how expensive individual health insurance might be under the Affordable Care Act. Proposed rates there, while of questionable relevance to the rest of the country because of the state’s unusual insurance market, showed little change from current prices and reassured health law supporters fearing headlines about “sticker shock.”
But rate disclosure elsewhere may take a while. In many states the deadlines for filing proposed plans aren’t until late May. And some states with early deadlines have no plans to publish results as quickly. Vermont insurers had to file paperwork by March 25, and the state disclosed results on April 1.
“The state of Vermont is very intent on transparency,” said Dale Schaft, spokeswoman for the Vermont Department of Financial Regulation.
In New York, proposed rates from insurers are due Friday, April 12. But under state law, new insurance filings are not made public until they are approved by state regulators, which is anticipated in July, said a spokesman for the state health department.
Read the full story here: http://bit.ly/122LLvJ
Source: Kaiser Health News
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
2 Commerce Drive
Cranbury, NJ 08512